Predictive
Oncology (NASDAQ: POAI), a developer of highly adaptable assessment methods
for cancer patients to help guide personalized treatments, employs its
proprietary smart tumor profiling and artificial intelligence (“AI”) platform
to predict tumor drug response and improve clinical outcomes for cancer
patients. An article discussing the company’s activities further reads, “Last
year, POAI, then known as Precision Therapeutics, formed TumorGenesis to focus
on innovative ways to create improved patient-derived (PDx) tumor models. Currently,
TumorGenesis is working on developing new techniques for growing tumors in the
lab to generate more relevant models of the tumors that can be used to test
drugs for personalized therapy or aid in development of new medications. . .
.The approach is designed to grow tumors in the lab by providing an environment
that closely mimics the human body through the use of chemistry, biology,
mechanics and cell nutrients. In addition to this exclusive technology being
quicker and more affordable than existing PDx animal models, researchers
anticipate that the approach will better replicate the characteristics of
tumors. Initially, the company plans to develop PDx models for multiple
myeloma, triple-negative breast cancer and ovarian cancer, but Predictive is
expecting the technology to ultimately benefit oncologists who are
investigating other cancer areas as well, including liver, pancreatic, lung and
colon.”
To view the full article, visit http://ibn.fm/pALP6
About Predictive Oncology Inc.
Predictive Oncology operates in two business areas: first,
applying artificial intelligence to personalized medicine and drug discovery to
provide personalized medicine solutions for patients and clinicians as well as
clients in the pharmaceutical, diagnostic and biotech industries; and second,
production of the FDA-approved STREAMWAY(R) System for automated,
direct-to-drain medical fluid disposal. For more information, visit the
company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment